Venable will be a sponsor at this year's SupplySide West Global Expo & Conference. This conference focuses on the exploration, discovery, innovation, and marketing strategy around the development of finished consumer goods in the animal nutrition, beverage, cosmetics, dietary supplements, sports nutrition, food, and pharmaceutical industries.
Be sure to visit us at booth #1845 to meet our team and for more information on how you can take your product from research and development to regulatory approval and beyond!
To set up a meeting with us at the conference, please contact Camille King at CRKing@Venable.com.
To view the full conference agenda or to register, please click here.
Venable Events at SupplySide West
|
Tuesday, October 6, 2015, 11:00 a.m. - 12:20 p.m. PT Todd Harrison will speak on a panel, Ingredient & Technology Innovation: Firm Foundational Steps to Commercialization, that will discuss key considerations on clinical research, legal, IP & regulatory landscaping, and commercialization and go-to-market strategies. | |
|
| |
|
Wednesday, October 7, 2015, 12:00 p.m. - 12:50 p.m. PT | |
|
Special In-Booth Reception | |
|
Venable's food and drug practice operates at the intersection of the FDA and the FTC, and has decades of marketplace experience assisting clients at all stages of the product life cycle. Come meet the team and let us tell you how we can help your product move from development and regulatory approval/clearance to advertising, marketing and distribution. We look forward to meeting with you! In Case You Missed It… NCN Conference Call: Trends in the Business of Nutrition Science: A clinical and legal perspective on developing and positioning products for health claims. Venable partnered with NCN's continued series on overcoming business challenges in the nutrition and health & wellness industry with a webinar-type discussion on the science-clinicals-claims continuum, and how companies can best plan and execute cost-effective clinical trials and pattern product claims in a legal context. This free conference call was led by Najla Guthrie, CEO of KGK Synergize, and Todd Harrison, Co-Chair of the FDA Practice at Venable LLP, who presented brief summaries of their points of view, followed by a discussion facilitated by NCN and involving questions emailed or posted by participants. | |
